Changing trends in hepatitis C-related mortality in the United States, 1995-2004

Matthew Wise1, Stephanie Bialek, Lyn Finelli

  • 1Department of Epidemiology, School of Public Health, University of California, Los Angeles, CA 90095-1772, USA. mawise@ph.lacounty.gov

Insights

Hepatitis C mortality in the US increased 123% from 1995-2004, especially in older males and minority groups. Despite recent declines, rates continue to rise in those aged 55-64, highlighting hepatitis C as a significant cause of premature death.

Area of Science:

  • Hepatology
  • Public Health
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) infection poses a growing disease burden in the US.
  • Increasing numbers of individuals with long-standing chronic hepatitis C infections are predicted to drive future mortality.
  • Understanding trends in hepatitis C-related deaths is crucial for public health interventions.

Purpose of the Study:

  • To analyze hepatitis C mortality rates in the United States from 1995 to 2004.
  • To identify demographic groups disproportionately affected by hepatitis C mortality.
  • To assess the impact of hepatitis C on potential years of life lost.

Main Methods:

  • Analysis of US Census and multiple-cause-of-death data from 1995-2004.
  • Inclusion criteria for hepatitis C-related deaths: HCV as underlying cause, chronic liver disease with HCV as contributing cause, or HIV with chronic liver disease and HCV as contributing causes.
  • Calculation of mortality rates per 100,000 persons and years of potential life lost.

Main Results:

  • A total of 56,409 hepatitis C-related deaths were identified between 1995 and 2004.
  • Overall mortality rates increased by 123%, from 1.09 to 2.44 per 100,000 persons.
  • Increases were higher among males, non-Hispanic blacks, and Native Americans; rates continued to rise in those aged 55-64, despite a slight overall decline after 2002.

Conclusions:

  • Hepatitis C mortality has significantly increased since 1995.
  • Hepatitis C remains an important cause of premature mortality in the United States.
  • Targeted interventions are needed, particularly for aging populations and specific demographic groups experiencing rising mortality rates.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...